Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients?

Journal of Clinical Psychiatry

Volumn 62, Issue 10, 2001, Pages 776-781

  Trivedi, M H ^a   Rush, A J ^a   Carmody, T J ^a   Donahue, R M J ^a   Bolden Watson, C ^a   Houser, T L ^a   Metz, A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; FLUOXETINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; PLACEBO; PROTRIPTYLINE; SERTRALINE; VENLAFAXINE;

ADULT; AGED; AGITATION; ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SOMNOLENCE; SUSTAINED RELEASE PREPARATION; TRANQUILIZING ACTIVITY; TREMOR; VERTIGO;

EID: 0035190830     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n1005     Document Type: Article

References (19)

1. A placebo-controlled comparison of the antidepressant and sexual functioning effects of bupropion sustained release and sertraline
2. Sexual dysfunction associated with the treatment of depression: A placebo-controlled comparison of bupropion sustained release and sertraline treatment
3. A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion SR tablets versus placebo in depressed outpatients
4. Antidepressant efficacy of sertraline: A double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression
5. Sertraline safety and efficacy in major depression: A double-blind fixed-dose comparison with placebo
6. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression
7. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly
8. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients
9. Targeting treatment in patients with mixed symptoms of anxiety and depression
10. Does pretreatment anxiety predict response to either bupropion SR or sertraline?
11. A rating scale for depression
12. Development of a rating scale for primary depressive illness
13. The assessment of anxiety states by rating
14. Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline